Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study

Fig. 2

Kaplan-Meier survival analysis of 28-day survival according to acute respiratory distress syndrome (ARDS) severity. The Kaplan-Meier survival curves censored at day 28 for each ARDS group (mild, moderate, and severe). The mortality risk among the patients under study was higher for those with severe ARDS compared with those with mild and moderate ARDS (P <0.0001, log-rank test)

Back to article page